Published in Gut Microbes on May 13, 2010
Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (2012) 7.54
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21
Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell (2015) 3.13
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J (2011) 2.92
A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol (2012) 2.56
The gut microbiome modulates colon tumorigenesis. MBio (2013) 2.45
Novel bacterial taxa in the human microbiome. PLoS One (2012) 2.35
Towards the human colorectal cancer microbiome. PLoS One (2011) 2.30
Fusobacterium is associated with colorectal adenomas. PLoS One (2013) 1.99
The gut microbiota and host health: a new clinical frontier. Gut (2015) 1.91
Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 1.63
Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J (2012) 1.62
Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One (2013) 1.62
Exploring host-microbiota interactions in animal models and humans. Genes Dev (2013) 1.51
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2011) 1.49
Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One (2013) 1.48
Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nat Commun (2014) 1.47
The gut microbiota in conventional and serrated precursors of colorectal cancer. Microbiome (2016) 1.45
Pyrosequencing-based analysis of the mucosal microbiota in healthy individuals reveals ubiquitous bacterial groups and micro-heterogeneity. PLoS One (2011) 1.38
Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol (2014) 1.35
Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J (2012) 1.33
Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis (2015) 1.33
Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome (2014) 1.27
Evolutionary foundations for cancer biology. Evol Appl (2013) 1.25
The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol (2011) 1.22
Bacterial oncogenesis in the colon. Future Microbiol (2013) 1.18
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol (2011) 1.18
Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett (2011) 1.12
Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma. Hum Mol Genet (2011) 1.09
Gastrointestinal malignancy and the microbiome. Gastroenterology (2014) 1.07
Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol (2014) 1.06
Microbiota disbiosis is associated with colorectal cancer. Front Microbiol (2015) 1.02
Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas. BMC Cancer (2013) 1.00
Fusobacterium and Enterobacteriaceae: important players for CRC? Immunol Lett (2014) 0.98
The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes (2013) 0.98
Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice. Inflamm Bowel Dis (2013) 0.97
Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med (2016) 0.97
The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol (2014) 0.94
Gut microbiome and colorectal adenomas. Cancer J (2014) 0.94
Probiotics as efficient immunopotentiators: translational role in cancer prevention. Indian J Med Res (2013) 0.90
Upper gastrointestinal microbiota and digestive diseases. World J Gastroenterol (2013) 0.89
Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) (2016) 0.88
Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota. Oncotarget (2015) 0.88
Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study. EBioMedicine (2015) 0.87
VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep (2013) 0.87
Colorectal cancer: CRC--all about microbial products and barrier function? Nat Rev Gastroenterol Hepatol (2012) 0.87
Altered tissue metabolites correlate with microbial dysbiosis in colorectal adenomas. J Proteome Res (2014) 0.87
Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment. Genome Med (2015) 0.87
Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas. Sci Rep (2015) 0.87
Fusobacterium spp. and colorectal cancer: cause or consequence? Trends Microbiol (2013) 0.86
Differences in microbial signatures between rectal mucosal biopsies and rectal swabs. Gut Microbes (2012) 0.84
Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain. Gut Microbes (2015) 0.83
Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Therap Adv Gastroenterol (2013) 0.83
Animal models to study acute and chronic intestinal inflammation in mammals. Gut Pathog (2015) 0.83
Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas. Sci Rep (2016) 0.81
Soluble plantain fibre blocks adhesion and M-cell translocation of intestinal pathogens. J Nutr Biochem (2012) 0.81
Reduced insulin-like growth factor I receptor and altered insulin receptor isoform mRNAs in normal mucosa predict colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2014) 0.81
Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget (2015) 0.80
The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real? Trends Cancer (2015) 0.80
The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis. Curr Gastroenterol Rep (2013) 0.79
Altered Interactions between the Gut Microbiome and Colonic Mucosa Precede Polyposis in APCMin/+ Mice. PLoS One (2015) 0.79
The dietary polysaccharide maltodextrin promotes Salmonella survival and mucosal colonization in mice. PLoS One (2014) 0.79
A randomised trial of sheathed versus standard forceps for obtaining uncontaminated biopsy specimens of microbiota from the terminal ileum. Gut (2011) 0.79
Cutting Edge: Retinoic Acid Signaling in B Cells Is Essential for Oral Immunization and Microflora Composition. J Immunol (2015) 0.79
Systemic folate status, rectal mucosal folate concentration and dietary intake in patients at differential risk of bowel cancer (The FAB2 Study). Eur J Nutr (2012) 0.78
Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk. Nutr Cancer (2013) 0.78
Clinical detection of human probiotics and human pathogenic bacteria by using a novel high-throughput platform based on next generation sequencing. J Clin Bioinforma (2014) 0.77
Diet- and Genetically-Induced Obesity Differentially Affect the Fecal Microbiome and Metabolome in Apc1638N Mice. PLoS One (2015) 0.77
Manipulation of the Gut Microbiota Reveals Role in Colon Tumorigenesis. mSphere (2015) 0.77
Shifts in the fecal microbiota associated with adenomatous polyps. Cancer Epidemiol Biomarkers Prev (2016) 0.77
The Role of the Microbiome in Gastrointestinal Cancer. Gastroenterol Clin North Am (2016) 0.77
Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin. Gut Microbes (2015) 0.76
Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol (2016) 0.76
Body mass index as a predictor of advanced colorectal neoplasia. J Cancer Prev (2013) 0.76
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep (2017) 0.76
The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis. Clin Lab Med (2014) 0.76
The common prophylactic therapy for bowel surgery is ineffective for clearing Bacteroidetes, the primary inducers of systemic inflammation, and causes faster death in response to intestinal barrier damage in mice. BMJ Open Gastroenterol (2015) 0.75
Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients. World J Gastroenterol (2016) 0.75
Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research. Front Cell Infect Microbiol (2017) 0.75
Highly Heterogeneous Probiotic Lactobacillus Species in Healthy Iranians with Low Functional Activities. PLoS One (2015) 0.75
Role of the Microbiota in Colorectal Cancer: Updates on Microbial Associations and Therapeutic Implications. Biores Open Access (2016) 0.75
Novel Method for Screening Colorectal Neoplasm. EBioMedicine (2015) 0.75
What influences preneoplastic colorectal lesion recurrence? Oncotarget (2016) 0.75
Use of the Analysis of the Volatile Faecal Metabolome in Screening for Colorectal Cancer. PLoS One (2015) 0.75
Current Hypothesis for the Relationship between Dietary Rice Bran Intake, the Intestinal Microbiota and Colorectal Cancer Prevention. Nutrients (2016) 0.75
Early maternal separation induces alterations of colonic epithelial permeability and morphology. Pediatr Surg Int (2014) 0.75
Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma. Dig Dis Sci (2016) 0.75
Development and Validation of a High-Throughput Mass Spectrometry Based Urine Metabolomic Test for the Detection of Colonic Adenomatous Polyps. Metabolites (2017) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol (2007) 60.97
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
Diversity of the human intestinal microbial flora. Science (2005) 49.64
Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98
Host-bacterial mutualism in the human intestine. Science (2005) 26.39
UniFrac--an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics (2006) 25.13
NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes. Nucleic Acids Res (2006) 23.67
Development of the human infant intestinal microbiota. PLoS Biol (2007) 18.91
Phylogenetic approaches for describing and comparing the diversity of microbial communities. Appl Environ Microbiol (2002) 18.69
Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol (1977) 17.41
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol (2008) 16.57
Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol (2007) 11.88
Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20
Global patterns in bacterial diversity. Proc Natl Acad Sci U S A (2007) 8.00
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86
Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol (2002) 6.79
Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol (2002) 6.74
Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr (1999) 5.13
Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat Immunol (2004) 4.58
The core gut microbiome, energy balance and obesity. J Physiol (2009) 4.45
Statistical methods for characterizing diversity of microbial communities by analysis of terminal restriction fragment length polymorphisms of 16S rRNA genes. Environ Microbiol (2006) 3.44
Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis (2005) 2.93
Terminal restriction fragment length polymorphism data analysis for quantitative comparison of microbial communities. Appl Environ Microbiol (2003) 2.82
Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis (2009) 2.44
Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res (2002) 2.12
Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr Res (2004) 2.00
Bacteria as the cause of ulcerative colitis. Gut (2001) 1.96
Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut (2000) 1.92
Phylogenetic identification of uncultured pathogens using ribosomal RNA sequences. Methods Enzymol (1994) 1.83
Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut (2006) 1.81
Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol (2002) 1.79
Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis (2002) 1.76
Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis (2008) 1.72
Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) (2004) 1.51
Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol (2007) 1.48
Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J (2009) 1.43
Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol (2008) 1.42
Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol (2007) 1.35
Patterns and scales in gastrointestinal microbial ecology. Gastroenterology (2009) 1.33
Characterization of microbial communities found in the human vagina by analysis of terminal restriction fragment length polymorphisms of 16S rRNA genes. Appl Environ Microbiol (2005) 1.29
Hydrogen sulfide induces direct radical-associated DNA damage. Mol Cancer Res (2007) 1.27
Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis (2005) 1.22
Molecular analysis of cytolysin A (ClyA) in pathogenic Escherichia coli strains. J Bacteriol (2004) 1.17
Role of bacteria in experimental colitis. Best Pract Res Clin Gastroenterol (2003) 1.14
Role of intestinal epithelial cells in the innate immune defence of the pig intestine. Vet Res (2006) 1.12
Effects of intestinal bacteria on the development of colonic neoplasm: an experimental study. Eur J Cancer Prev (1999) 1.12
Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces. Microbiol Immunol (2002) 1.06
Management of small intestinal bacterial overgrowth. Curr Gastroenterol Rep (2005) 1.04
Impact of commensal microbiota on murine gastrointestinal tract gene ontologies. Physiol Genomics (2004) 1.04
A role of lipophilic peptidoglycan-related molecules in induction of Nod1-mediated immune responses. J Biol Chem (2007) 1.01
Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity. Int J Oncol (2008) 1.00
Anaerobic bacterial populations on normal and diseased human biopsy tissue obtained at colonoscopy. Appl Environ Microbiol (1982) 0.99
Effect of colonic bacterial metabolites on Caco-2 cell paracellular permeability in vitro. Nutr Cancer (2008) 0.96
Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies. Cancer (1996) 0.88
The effects of maturation on the colonic microflora in infancy and childhood. Gastroenterol Res Pract (2009) 0.87
Factors involved in the production of tissue damage by endotoxins derived from Gram-negative micro-organisms. AMA Am J Dis Child (1953) 0.79
Gut flora in gastrointestinal disease. Eur J Surg Suppl (2002) 0.78
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med (2005) 15.46
Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A (2010) 12.39
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (2012) 7.54
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
Animals in a bacterial world, a new imperative for the life sciences. Proc Natl Acad Sci U S A (2013) 5.03
Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58
Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J (2007) 4.36
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology (2005) 4.31
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79
Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science (2009) 3.71
Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst (2003) 3.44
Clinical practice. Screening for colorectal cancer. N Engl J Med (2002) 3.43
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology (2006) 3.35
Constipation and a low-fiber diet are not associated with diverticulosis. Clin Gastroenterol Hepatol (2013) 3.31
Evidence for a core gut microbiota in the zebrafish. ISME J (2011) 3.22
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst (2009) 3.15
A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology (2011) 3.03
Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol (2007) 2.94
The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol (2006) 2.93
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med (2015) 2.88
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet (2008) 2.83
Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2010) 2.80
A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy. Am J Gastroenterol (2002) 2.75
Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst (2009) 2.64
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet (2011) 2.43
Advances in the use of terminal restriction fragment length polymorphism (T-RFLP) analysis of 16S rRNA genes to characterize microbial communities. Appl Microbiol Biotechnol (2008) 2.36
Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS One (2012) 2.34
RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Invest (2007) 2.25
Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. J Clin Oncol (2004) 2.24
Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis (2012) 2.23
KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer. Mol Cancer Ther (2009) 2.22
Performance-based selection of likelihood models for phylogeny estimation. Syst Biol (2003) 2.15
Digestive and liver diseases statistics, 2004. Gastroenterology (2004) 2.14
A causal association between isotretinoin and inflammatory bowel disease has yet to be established. Am J Gastroenterol (2009) 2.14
Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13
Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol (2010) 2.10
Microbiota of the seminal fluid from healthy and infertile men. Fertil Steril (2013) 2.10
Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One (2011) 2.09
Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol (2003) 2.06
Fusobacterium is associated with colorectal adenomas. PLoS One (2013) 1.99
Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology (2012) 1.97
Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe (2012) 1.93
Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol (2013) 1.83
Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst (2003) 1.80
Host-microbe interactions in the developing zebrafish. Curr Opin Immunol (2010) 1.76
Patient time requirements for screening colonoscopy. Am J Gastroenterol (2007) 1.74
Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst (2007) 1.73
Editorial: colonoscopy and colorectal cancer mortality: strong beliefs or strong facts? Am J Gastroenterol (2010) 1.71
Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol (2013) 1.71
Suboptimal rates of cervical testing among women with inflammatory bowel disease. Clin Gastroenterol Hepatol (2008) 1.71
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology (2003) 1.70
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut (2011) 1.70
Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology (2004) 1.70
Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci (2010) 1.68
Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst (2004) 1.67
Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol (2011) 1.66
Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J (2012) 1.62
Ontogeny and nutritional control of adipogenesis in zebrafish (Danio rerio). J Lipid Res (2009) 1.58
Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2005) 1.52
Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl (2002) 1.52
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2011) 1.49
Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. Am J Obstet Gynecol (2005) 1.49
Relationship of EMAST and microsatellite instability among patients with rectal cancer. J Gastrointest Surg (2010) 1.48
Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev (2002) 1.48
Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease. J Clin Gastroenterol (2016) 1.47
Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev (2005) 1.45
Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study. Med Decis Making (2008) 1.45
Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev (2004) 1.45
Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect Dis Obstet Gynecol (2010) 1.43
Evaluating the performance of a successive-approximations approach to parameter optimization in maximum-likelihood phylogeny estimation. Mol Biol Evol (2005) 1.42
Microbial colonization induces dynamic temporal and spatial patterns of NF-κB activation in the zebrafish digestive tract. Gastroenterology (2011) 1.39
Acid-sensing ion channels in malignant gliomas. J Biol Chem (2003) 1.38
Research recruitment through US central cancer registries: balancing privacy and scientific issues. Am J Public Health (2006) 1.37
Identifying specific chemotherapeutic agents in Medicare data: a validation study. Med Care (2013) 1.36
Methods for generating and colonizing gnotobiotic zebrafish. Nat Protoc (2008) 1.35
Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.33
Social ties and colorectal cancer screening among Blacks and Whites in North Carolina. Cancer Epidemiol Biomarkers Prev (2005) 1.31
Genetic heterogeneity in colorectal cancer associations between African and European americans. Gastroenterology (2010) 1.31
Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev (2003) 1.29
Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci (2012) 1.27
IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol (2002) 1.25
Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int J Cancer (2006) 1.22
Impact of the 2008-2009 economic recession on screening colonoscopy utilization among the insured. Clin Gastroenterol Hepatol (2011) 1.21
Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology (2006) 1.21
The genetics of adaptation for eight microvirid bacteriophages. J Mol Evol (2009) 1.20